| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 82,884 | 163,535 | ||
| Short-term investments | 124,233 | 61,983 | ||
| Restricted cash | 338 | 338 | ||
| Inventory | 4,850 | 2,686 | ||
| Other receivables | 1,616 | 1,630 | ||
| Prepaid expenses and other current assets | 2,209 | 2,090 | ||
| Total current assets | 216,130 | 232,262 | ||
| Subtotal | 26,694 | - | ||
| Less accumulated depreciation | 16,356 | - | ||
| Property and equipment, net | 10,338 | 9,489 | ||
| Operating lease right-of-use assets | 4,086 | 4,144 | ||
| Other assets | 541 | 338 | ||
| Total assets | 231,095 | 246,233 | ||
| Accounts payable | 5,927 | 7,337 | ||
| Accrued expenses | 6,888 | 5,495 | ||
| Current portion of long-term debt | 8,889 | 5,556 | ||
| Current portion of operating lease liability | 102 | 537 | ||
| Accrued taxes | 339 | 15,512 | ||
| Other current liabilities | 35 | 80 | ||
| Total current liabilities | 22,180 | 34,517 | ||
| Long-term operating lease liabilities | 4,254 | 3,978 | ||
| Long-term debt | 10,862 | 14,005 | ||
| Warrant liabilities | 22,566 | 30,157 | ||
| Total liabilities | 59,862 | 82,657 | ||
| Common stock - 0.01 par value authorized 200,000,000 shares 52,400,415 and 45,644,091 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 524 | 512 | ||
| Additional paid-in capital | 892,314 | 879,563 | ||
| Accumulated deficit | -721,615 | -716,454 | ||
| Accumulated other comprehensive income | 10 | -45 | ||
| Total stockholders equity | 171,233 | 163,576 | ||
| Total liabilities and stockholders equity | 231,095 | 246,233 | ||
ABEONA THERAPEUTICS INC. (ABEO)
ABEONA THERAPEUTICS INC. (ABEO)